• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
COV
Click for more information
4.48% 32.0¢

CLEO DIAGNOSTICS LTD - Charts / Financials

Market Cap $26.11M  ! watchlist Created with Sketch. Add to my watchlist

Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal... Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal activities involve the development and patent of a blood test for the detection of ovarian cancer. It focuses on bringing to market a blood test for the early diagnosis of ovarian cancer based on the novel CXCL10 biomarker, which is produced early and at high levels by ovarian cancers but is largely absent in non-malignant disease. It is advancing the availability of its blood test, under a modular execution strategy, which is designed to address all ovarian cancer detection markets with specific tests, including surgical triage, recurrence, high risk, and early-stage screening. It has developed a three-phased product development strategy that delivers three related tests for ovarian cancer detection: Triage Test, Recurrence Test, and Screening Test. Triage Test is a pre-surgical test to determine the likelihood that a pre-surgical ovarian mass in a patient not yet referred to an oncologist, is malignant.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 10.46am 22/07/2024 (20 minute delay) ?
Day
Open 32.5¢   Day High 32.5¢   Day Low 31.0¢
Daily Volume 222882
Bids   Sellers
Number Price Volume   Number Price Volume
1 31.5¢ 10000   2 34.0¢ 29329

Directors & Senior Management

Dr. Richard Allman Chief Executive Officer, Executive Director
Dr. Andrew N. Stephens Chief Scientific Officer, Executive Director
Prof. Thomas W. Jobling Non-Executive Independent Director, Lead Medical Advisor
Ms. Pauline M. Moffatt Company Secretary
Mr. Adrien Michele Wing Non-Executive Chairman of the Board
Ms. Lucinda J. Nolan Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
32.0¢ 		Change
-0.015(4.48%) 		Mkt cap ! $26.11M
Open High Low Value Volume
32.5¢ 32.5¢ 31.0¢ $70.84K 222.8K

Buyers (Bids)

No. Vol. Price($)
1 10000 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 29329 2
View Market Depth
Last trade - 15.00pm 22/07/2024 (20 minute delay) ?
Last
32.0¢ 		  Change
-0.015 ( 4.48 %)
Open High Low Volume
32.0¢ 32.0¢ 31.5¢ 10992
Last updated 10.46am 22/07/2024 ?

Top Stories

High-grade copper results provide some relief to 29Metals after earlier mine shutdown

29Metals Ltd has reported positive results from a 3-hole program of drilling in Queensland, finding up to 4.8% copper.
HBF to throw 10% vote behind NDC BidCo's buyout of Pacific Smiles Group Pacific Smiles Group has confirmed 10% shareholder HBF – the private health insurer – will vote in favour of PSQ's buyout by NDC BidCo.
Biden's exit bakes in a Kamala Harris ballot while markets expect Trump to win. How could equities fare this week? Joe Biden, current US President, has agreed to drop out of the 2024 Presidential election following internal disagreement.
Large fault structure and uranium anomalies picked up by Infini at Newfoundland play Infini Resources Ltd has revealed the presence of a large fault structure connected to anomalies at its Portland Creek uranium project.
Pure Hydrogen inks MOU for 5 hydrogen buses in Saigon – days after Twiggy's FFI reeled back in Pure Hydrogen has confirmed it's executed an MOU with a Vietnam-based entity to develop hydrogen-fuelled buses.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.